Radiochemotherapie des Harnblasenkarzinoms View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-12

AUTHORS

C. Rödel, C. Weiss, R. Sauer

ABSTRACT

Standardbehandlung des muskelinvasiven Harnblasenkarzinoms ist die radikale Zystektomie. Einige Gruppen untersuchen den Stellenwert einer multimodalen, organerhaltenden Therapie unter Einsatz der transurethralen Tumorresektion (TUR) in Kombination mit einer Radiochemotherapie. Bei diesem Konzept wird die Zystektomie auf Patienten beschränkt, die keine komplette Remission erreichen oder ein invasives Rezidiv entwickeln. Die Fünfjahresüberlebensraten betragen nach dieser organerhaltenden Therapieform 50–60%; etwa 80% der überlebenden Patienten behalten ihre eigene, gut funktionierende Blase. Die multimodale Behandlung des Blasenkarzinoms stellt somit eine Alternative für Patienten dar, die einen Organerhalt anstreben. Ideale Kandidaten für dieses Vorgehen sind Patienten mit frühen Tumorstadien und unifokalen Tumoren, bei denen die initiale TUR eine R0-Situation schafft. More... »

PAGES

1096-1100

Journal

TITLE

Der Onkologe

ISSUE

12

VOLUME

13

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00761-007-1284-y

DOI

http://dx.doi.org/10.1007/s00761-007-1284-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027972069


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "author": [
      {
        "affiliation": {
          "alternateName": "Goethe University Frankfurt", 
          "id": "https://www.grid.ac/institutes/grid.7839.5", 
          "name": [
            "Klinik f\u00fcr Strahlentherapie und Onkologie, Johann Wolfgang Goethe-Universit\u00e4t Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "R\u00f6del", 
        "givenName": "C.", 
        "id": "sg:person.01110566562.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110566562.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Goethe University Frankfurt", 
          "id": "https://www.grid.ac/institutes/grid.7839.5", 
          "name": [
            "Klinik f\u00fcr Strahlentherapie und Onkologie, Johann Wolfgang Goethe-Universit\u00e4t Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weiss", 
        "givenName": "C.", 
        "id": "sg:person.01337331714.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337331714.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Erlangen-Nuremberg", 
          "id": "https://www.grid.ac/institutes/grid.5330.5", 
          "name": [
            "Strahlenklinik, Universit\u00e4t Erlangen, Erlangen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sauer", 
        "givenName": "R.", 
        "id": "sg:person.0722130722.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722130722.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.5-6-471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000208867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(03)00718-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000741071"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(03)00718-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000741071"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urology.2006.05.060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015294376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-5347(01)62379-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017223503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0090-4295(01)01219-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017732113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.10.070", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021866484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(93)90306-g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022330978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(97)00579-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032625558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2004.05.074", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033089555"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.11.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.07.6729", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204353"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.3.666", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074750670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.1.119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082858541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.11.2901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082998128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.3.1022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083057217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.11.3576", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083348415"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-12", 
    "datePublishedReg": "2007-12-01", 
    "description": "Standardbehandlung des muskelinvasiven Harnblasenkarzinoms ist die radikale Zystektomie. Einige Gruppen untersuchen den Stellenwert einer multimodalen, organerhaltenden Therapie unter Einsatz der transurethralen Tumorresektion (TUR) in Kombination mit einer Radiochemotherapie. Bei diesem Konzept wird die Zystektomie auf Patienten beschr\u00e4nkt, die keine komplette Remission erreichen oder ein invasives Rezidiv entwickeln. Die F\u00fcnfjahres\u00fcberlebensraten betragen nach dieser organerhaltenden Therapieform 50\u201360%; etwa 80% der \u00fcberlebenden Patienten behalten ihre eigene, gut funktionierende Blase. Die multimodale Behandlung des Blasenkarzinoms stellt somit eine Alternative f\u00fcr Patienten dar, die einen Organerhalt anstreben. Ideale Kandidaten f\u00fcr dieses Vorgehen sind Patienten mit fr\u00fchen Tumorstadien und unifokalen Tumoren, bei denen die initiale TUR eine R0-Situation schafft.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00761-007-1284-y", 
    "inLanguage": [
      "de"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1119546", 
        "issn": [
          "0947-8965", 
          "1433-0415"
        ], 
        "name": "Der Onkologe", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "name": "Radiochemotherapie des Harnblasenkarzinoms", 
    "pagination": "1096-1100", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "85400956f1e6a64f5308fc9064747f6902cb2ec146cc34d7ee1734f9dd2cf102"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00761-007-1284-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027972069"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00761-007-1284-y", 
      "https://app.dimensions.ai/details/publication/pub.1027972069"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13093_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00761-007-1284-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00761-007-1284-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00761-007-1284-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00761-007-1284-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00761-007-1284-y'


 

This table displays all metadata directly associated to this object as RDF triples.

118 TRIPLES      20 PREDICATES      41 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00761-007-1284-y schema:author Na98ee13356e94ab6b21f9b6f60b0478c
2 schema:citation https://doi.org/10.1016/0360-3016(93)90306-g
3 https://doi.org/10.1016/j.ijrobp.2004.05.074
4 https://doi.org/10.1016/j.urology.2006.05.060
5 https://doi.org/10.1016/s0022-5347(01)62379-6
6 https://doi.org/10.1016/s0090-4295(01)01219-5
7 https://doi.org/10.1016/s0360-3016(03)00718-1
8 https://doi.org/10.1016/s0360-3016(97)00579-8
9 https://doi.org/10.1200/jco.1996.14.1.119
10 https://doi.org/10.1200/jco.1996.14.11.2901
11 https://doi.org/10.1200/jco.1997.15.3.1022
12 https://doi.org/10.1200/jco.1998.16.11.3576
13 https://doi.org/10.1200/jco.2001.19.3.666
14 https://doi.org/10.1200/jco.2002.11.027
15 https://doi.org/10.1200/jco.2004.10.070
16 https://doi.org/10.1200/jco.2006.07.6729
17 https://doi.org/10.1634/theoncologist.5-6-471
18 schema:datePublished 2007-12
19 schema:datePublishedReg 2007-12-01
20 schema:description Standardbehandlung des muskelinvasiven Harnblasenkarzinoms ist die radikale Zystektomie. Einige Gruppen untersuchen den Stellenwert einer multimodalen, organerhaltenden Therapie unter Einsatz der transurethralen Tumorresektion (TUR) in Kombination mit einer Radiochemotherapie. Bei diesem Konzept wird die Zystektomie auf Patienten beschränkt, die keine komplette Remission erreichen oder ein invasives Rezidiv entwickeln. Die Fünfjahresüberlebensraten betragen nach dieser organerhaltenden Therapieform 50–60%; etwa 80% der überlebenden Patienten behalten ihre eigene, gut funktionierende Blase. Die multimodale Behandlung des Blasenkarzinoms stellt somit eine Alternative für Patienten dar, die einen Organerhalt anstreben. Ideale Kandidaten für dieses Vorgehen sind Patienten mit frühen Tumorstadien und unifokalen Tumoren, bei denen die initiale TUR eine R0-Situation schafft.
21 schema:genre research_article
22 schema:inLanguage de
23 schema:isAccessibleForFree false
24 schema:isPartOf N0e61e6c168ba4e7192bc008b9c326878
25 N9dac0327551b4ce38264c921305054d4
26 sg:journal.1119546
27 schema:name Radiochemotherapie des Harnblasenkarzinoms
28 schema:pagination 1096-1100
29 schema:productId N3975e812cbc540f081db8f23b4cdf8ce
30 N6016bf9703b6401183852d274ab12421
31 Ne0e277ac035144ceac892a103f9d8f5b
32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027972069
33 https://doi.org/10.1007/s00761-007-1284-y
34 schema:sdDatePublished 2019-04-11T14:30
35 schema:sdLicense https://scigraph.springernature.com/explorer/license/
36 schema:sdPublisher N25226b9fb75345068dc7353d365f3ddd
37 schema:url http://link.springer.com/10.1007%2Fs00761-007-1284-y
38 sgo:license sg:explorer/license/
39 sgo:sdDataset articles
40 rdf:type schema:ScholarlyArticle
41 N0e61e6c168ba4e7192bc008b9c326878 schema:issueNumber 12
42 rdf:type schema:PublicationIssue
43 N25226b9fb75345068dc7353d365f3ddd schema:name Springer Nature - SN SciGraph project
44 rdf:type schema:Organization
45 N37c3cb1d3ba54fd6b052671ac9f99b33 rdf:first sg:person.0722130722.52
46 rdf:rest rdf:nil
47 N3975e812cbc540f081db8f23b4cdf8ce schema:name readcube_id
48 schema:value 85400956f1e6a64f5308fc9064747f6902cb2ec146cc34d7ee1734f9dd2cf102
49 rdf:type schema:PropertyValue
50 N6016bf9703b6401183852d274ab12421 schema:name doi
51 schema:value 10.1007/s00761-007-1284-y
52 rdf:type schema:PropertyValue
53 N9dac0327551b4ce38264c921305054d4 schema:volumeNumber 13
54 rdf:type schema:PublicationVolume
55 Na98ee13356e94ab6b21f9b6f60b0478c rdf:first sg:person.01110566562.10
56 rdf:rest Nf79c727acd254e97a0878f3702981f21
57 Ne0e277ac035144ceac892a103f9d8f5b schema:name dimensions_id
58 schema:value pub.1027972069
59 rdf:type schema:PropertyValue
60 Nf79c727acd254e97a0878f3702981f21 rdf:first sg:person.01337331714.32
61 rdf:rest N37c3cb1d3ba54fd6b052671ac9f99b33
62 sg:journal.1119546 schema:issn 0947-8965
63 1433-0415
64 schema:name Der Onkologe
65 rdf:type schema:Periodical
66 sg:person.01110566562.10 schema:affiliation https://www.grid.ac/institutes/grid.7839.5
67 schema:familyName Rödel
68 schema:givenName C.
69 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110566562.10
70 rdf:type schema:Person
71 sg:person.01337331714.32 schema:affiliation https://www.grid.ac/institutes/grid.7839.5
72 schema:familyName Weiss
73 schema:givenName C.
74 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337331714.32
75 rdf:type schema:Person
76 sg:person.0722130722.52 schema:affiliation https://www.grid.ac/institutes/grid.5330.5
77 schema:familyName Sauer
78 schema:givenName R.
79 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722130722.52
80 rdf:type schema:Person
81 https://doi.org/10.1016/0360-3016(93)90306-g schema:sameAs https://app.dimensions.ai/details/publication/pub.1022330978
82 rdf:type schema:CreativeWork
83 https://doi.org/10.1016/j.ijrobp.2004.05.074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033089555
84 rdf:type schema:CreativeWork
85 https://doi.org/10.1016/j.urology.2006.05.060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015294376
86 rdf:type schema:CreativeWork
87 https://doi.org/10.1016/s0022-5347(01)62379-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017223503
88 rdf:type schema:CreativeWork
89 https://doi.org/10.1016/s0090-4295(01)01219-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017732113
90 rdf:type schema:CreativeWork
91 https://doi.org/10.1016/s0360-3016(03)00718-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000741071
92 rdf:type schema:CreativeWork
93 https://doi.org/10.1016/s0360-3016(97)00579-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032625558
94 rdf:type schema:CreativeWork
95 https://doi.org/10.1200/jco.1996.14.1.119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082858541
96 rdf:type schema:CreativeWork
97 https://doi.org/10.1200/jco.1996.14.11.2901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082998128
98 rdf:type schema:CreativeWork
99 https://doi.org/10.1200/jco.1997.15.3.1022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083057217
100 rdf:type schema:CreativeWork
101 https://doi.org/10.1200/jco.1998.16.11.3576 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083348415
102 rdf:type schema:CreativeWork
103 https://doi.org/10.1200/jco.2001.19.3.666 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074750670
104 rdf:type schema:CreativeWork
105 https://doi.org/10.1200/jco.2002.11.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203167
106 rdf:type schema:CreativeWork
107 https://doi.org/10.1200/jco.2004.10.070 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021866484
108 rdf:type schema:CreativeWork
109 https://doi.org/10.1200/jco.2006.07.6729 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204353
110 rdf:type schema:CreativeWork
111 https://doi.org/10.1634/theoncologist.5-6-471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000208867
112 rdf:type schema:CreativeWork
113 https://www.grid.ac/institutes/grid.5330.5 schema:alternateName University of Erlangen-Nuremberg
114 schema:name Strahlenklinik, Universität Erlangen, Erlangen, Deutschland
115 rdf:type schema:Organization
116 https://www.grid.ac/institutes/grid.7839.5 schema:alternateName Goethe University Frankfurt
117 schema:name Klinik für Strahlentherapie und Onkologie, Johann Wolfgang Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland
118 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...